Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lon HK"'
Autor:
Solh, M, Bahlis, NJ, Raje, NS, Costello, CL, Dholaria, B, Levy, MY, Tomasson, MH, Dube, H, Damore, MA, Lon, HK, Basu, C, Skoura, A, Chan, EM, Trudel, S, Jakubowiak, A, Chu, MP, Gasparetto, C, Dalovisio, A, Sebag, M, Lesokhin, AM
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S195-S196
Autor:
Soltantabar P; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Sharma S; Oncology Research and Development, Pfizer Inc, San Diego, California, USA.; Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Wang D; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Lon HK; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Czibere A; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Hickmann A; Oncology Research and Development, Pfizer Inc, San Diego, California, USA., Elmeliegy M; Oncology Research and Development, Pfizer Inc, San Diego, California, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1258-1268. Date of Electronic Publication: 2024 Mar 08.
Autor:
Hanafin PO; GSK, Collegeville, PA, USA., Murthy A; University of Texas at Austin, Austin, TX, USA., Marathe D; Gilead Sciences, Morris Plains, NJ, USA., Diep JK; Ionis Pharmaceuticals, Inc, Carlsbad, CA, USA., Krishnatry AS; GSK, Collegeville, PA, USA., Lon HK; Pfizer Inc, San Diego, CA, USA., Shah DK; University at Buffalo, State University of New York, Buffalo, NY, USA., Ait-Oudhia S; Merck & Co., Inc, Kenilworth, New Jersey, USA. sb.manuscript.submission@gmail.com., Rao GG; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. gaurirao@live.unc.edu.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2023 Aug; Vol. 50 (4), pp. 243-250.
Autor:
Soltantabar P; Global Product Development, Pfizer Inc, San Diego, CA, USA., Lon HK; Global Product Development, Pfizer Inc, San Diego, CA, USA., Parivar K; Global Product Development, Pfizer Inc, San Diego, CA, USA., Wang DD; Global Product Development, Pfizer Inc, San Diego, CA, USA., Elmeliegy M; Global Product Development, Pfizer Inc, San Diego, CA, USA. Electronic address: Mohamed.Elmeliegy@pfizer.com.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2023 Feb; Vol. 182, pp. 103913. Date of Electronic Publication: 2023 Jan 19.
Autor:
Höglinger GU; German Center for Neurodegenerative Diseases, Munich, Germany; Department of Neurology, Technische Universität München, Munich, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany. Electronic address: hoeglinger.guenter@mh-hannover.de., Litvan I; Parkinson and Other Movement Disorders Center, University of California San Diego, La Jolla, CA, USA., Mendonca N; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Wang D; Data and Statistical Sciences, AbbVie Inc, North Chicago, IL, USA., Zheng H; Data and Statistical Sciences, AbbVie Inc, North Chicago, IL, USA., Rendenbach-Mueller B; Neuroscience, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany., Lon HK; Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Jin Z; Data and Statistical Sciences, AbbVie Inc, North Chicago, IL, USA., Fisseha N; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Budur K; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Gold M; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Ryman D; Neuroscience, AbbVie Inc, North Chicago, IL, USA., Florian H; Neuroscience, AbbVie Inc, North Chicago, IL, USA.
Publikováno v:
The Lancet. Neurology [Lancet Neurol] 2021 Mar; Vol. 20 (3), pp. 182-192.
Autor:
Lon HK; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Cheng L; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Nudurupati S; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Loebbert R; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Duan R; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Kalabic J; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA., Pang Y; Department of Clinical Pharmacology and Pharmacometrics, AbbVie Inc, North Chicago, IL, USA. Electronic address: yinuo.pang@abbvie.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2021 Mar; Vol. 43 (3), pp. 629-636. Date of Electronic Publication: 2021 Feb 03.
Autor:
Lon HK; AbbVie Inc., North Chicago, IL, USA., Mendonca N; AbbVie Inc., North Chicago, IL, USA., Goss S; AbbVie Inc., North Chicago, IL, USA., Othman AA; AbbVie Inc., North Chicago, IL, USA., Locke C; AbbVie Inc., North Chicago, IL, USA., Jin Z; AbbVie Inc., North Chicago, IL, USA., Rendenbach-Mueller B; AbbVie Inc., North Chicago, IL, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Apr; Vol. 8 (3), pp. 290-303. Date of Electronic Publication: 2018 Jul 27.
Oligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and Immunogenicity.
Autor:
Wang J; 1 Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA., Lon HK; 1 Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA.; 2 Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA., Lee SL; 3 Office of Hematology and Oncology Products, Office of New Drugs, US Food and Drug Administration, Silver Spring, MD, USA., Burckart GJ; 1 Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA., Pisetsky DS; 4 Medical Research Service, Durham VA Medical Center and Duke University Medical Center, Durham, NC, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2015 Nov; Vol. 49 (6), pp. 861-868.
Autor:
Lon HK; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo Buffalo, New York, 14214., DuBois DC; Department of Biological Sciences, University at Buffalo Buffalo, New York, 14260., Earp JC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration Silver Spring, Maryland, 20993., Almon RR; Department of Biological Sciences, University at Buffalo Buffalo, New York, 14260., Jusko WJ; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo Buffalo, New York, 14214.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2015 Oct; Vol. 3 (5), pp. e00169. Date of Electronic Publication: 2015 Aug 03.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2013 Dec; Vol. 40 (6), pp. 701-12.